SURGEX

SURGEX has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €86,767 and a net result of €58,536. Equity is growing by about 3.4% per year across the filed financial years. Its solvency ranks better than 58% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).